ketoconazole and ponatinib

ketoconazole has been researched along with ponatinib in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF	1
Dorer, DJ; Haluska, F; Narasimhan, NI; Niland, K; Sonnichsen, D	1

Reviews

1 review(s) available for ketoconazole and ponatinib

Article	Year
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators. European journal of medicinal chemistry, 2022, Jul-05, Volume: 237 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells	2022

Trials

1 trial(s) available for ketoconazole and ponatinib

Article	Year
Effects of ketoconazole on the pharmacokinetics of ponatinib in healthy subjects. Journal of clinical pharmacology, 2013, Volume: 53, Issue:9 Topics: Adult; Area Under Curve; Biological Availability; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Fusion Proteins, bcr-abl; Humans; Imidazoles; Ketoconazole; Male; Middle Aged; Protein-Tyrosine Kinases; Pyridazines; Young Adult	2013

Article

Year

Effects of ketoconazole on the pharmacokinetics of ponatinib in healthy subjects.

Journal of clinical pharmacology, 2013, Volume: 53, Issue:9

Topics: Adult; Area Under Curve; Biological Availability; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Fusion Proteins, bcr-abl; Humans; Imidazoles; Ketoconazole; Male; Middle Aged; Protein-Tyrosine Kinases; Pyridazines; Young Adult

2013